X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6806) 6806
Publication (486) 486
Book Review (111) 111
Newsletter (62) 62
Magazine Article (46) 46
Newspaper Article (28) 28
Book Chapter (16) 16
Dissertation (9) 9
Conference Proceeding (5) 5
Trade Publication Article (5) 5
Transcript (3) 3
Data Set (1) 1
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4856) 4856
alendronate (4627) 4627
female (3992) 3992
osteoporosis (3706) 3706
index medicus (2972) 2972
aged (2365) 2365
middle aged (2329) 2329
endocrinology & metabolism (1922) 1922
male (1904) 1904
bisphosphonates (1724) 1724
bone density conservation agents - therapeutic use (1701) 1701
alendronate - therapeutic use (1677) 1677
postmenopausal women (1559) 1559
osteoporosis - drug therapy (1499) 1499
bone density - drug effects (1460) 1460
osteoporosis, postmenopausal - drug therapy (1412) 1412
fractures (1346) 1346
women (1260) 1260
orthopedics (1214) 1214
diphosphonates - therapeutic use (1161) 1161
animals (1151) 1151
bone density (1108) 1108
bone-mineral density (1075) 1075
aged, 80 and over (1026) 1026
risk (1019) 1019
risk factors (966) 966
postmenopausal osteoporosis (926) 926
therapy (908) 908
drug therapy (876) 876
bone density conservation agents - adverse effects (868) 868
bone density conservation agents - administration & dosage (859) 859
bones (838) 838
medicine & public health (832) 832
rheumatology (825) 825
treatment outcome (823) 823
prevention (802) 802
alendronate - administration & dosage (779) 779
risedronate (762) 762
adult (744) 744
medicine, general & internal (744) 744
bisphosphonate (724) 724
density (716) 716
vertebral fractures (695) 695
bone mineral density (674) 674
alendronate - adverse effects (671) 671
diphosphonates - administration & dosage (655) 655
diphosphonates - adverse effects (654) 654
zoledronic acid (646) 646
health aspects (638) 638
rats (620) 620
care and treatment (594) 594
alendronate - pharmacology (589) 589
research (585) 585
endocrinology (572) 572
bone (568) 568
bone density conservation agents - pharmacology (530) 530
fractures, bone - prevention & control (520) 520
mineral density (508) 508
analysis (507) 507
pharmacology & pharmacy (496) 496
time factors (485) 485
hip fracture (468) 468
randomized-trial (466) 466
fracture (461) 461
etidronic acid - analogs & derivatives (452) 452
drug administration schedule (439) 439
bone remodeling - drug effects (435) 435
diphosphonates (435) 435
double-blind method (429) 429
administration, oral (421) 421
diphosphonates - pharmacology (418) 418
absorptiometry, photon (410) 410
risedronate sodium (408) 408
surgery (404) 404
teriparatide (389) 389
retrospective studies (387) 387
double-blind (384) 384
etidronic acid - therapeutic use (375) 375
denosumab (372) 372
bone and bones - drug effects (369) 369
turnover (366) 366
dosage and administration (362) 362
phosphonates (361) 361
osteoporosis - complications (360) 360
follow-up studies (358) 358
parathyroid-hormone (350) 350
abridged index medicus (343) 343
radiography (341) 341
biochemical markers (335) 335
dentistry, oral surgery & medicine (335) 335
pamidronate (326) 326
medicine, research & experimental (324) 324
hormone replacement therapy (321) 321
drug therapy, combination (313) 313
osteonecrosis (313) 313
trial (313) 313
osteoporosis - prevention & control (309) 309
in-vitro (307) 307
bone turnover (303) 303
dentistry (303) 303
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6559) 6559
German (121) 121
Japanese (99) 99
Spanish (47) 47
French (44) 44
Chinese (24) 24
Korean (18) 18
Russian (15) 15
Portuguese (14) 14
Italian (12) 12
Polish (11) 11
Turkish (11) 11
Danish (9) 9
Norwegian (9) 9
Dutch (6) 6
Slovak (5) 5
Croatian (4) 4
Hungarian (4) 4
Swedish (4) 4
Czech (3) 3
Serbian (2) 2
Slovenian (2) 2
Bulgarian (1) 1
Finnish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2009, Volume 361, Issue 8, pp. 745 - 755
Men receiving androgen-deprivation therapy for nonmetastatic prostate cancer are at high risk for bone loss and fractures. This placebo-controlled study... 
ZOLEDRONIC ACID | MEDICINE, GENERAL & INTERNAL | PLACEBO | BONE-MINERAL DENSITY | FRACTURES | RISK | COMPLICATIONS | RANDOMIZED CONTROLLED-TRIAL | POSTMENOPAUSAL WOMEN | OSTEOPOROSIS | ALENDRONATE | Lumbar Vertebrae - injuries | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Fractures, Bone - epidemiology | Antibodies, Monoclonal - therapeutic use | Male | Osteoporosis - drug therapy | Prostatic Neoplasms - physiopathology | Bone Remodeling - drug effects | Incidence | Antibodies, Monoclonal, Humanized | Spinal Fractures - prevention & control | RANK Ligand - pharmacology | Injections, Subcutaneous | Aged, 80 and over | RANK Ligand - therapeutic use | Gonadotropin-Releasing Hormone - agonists | Lumbar Vertebrae - physiology | Prostatic Neoplasms - drug therapy | RANK Ligand - adverse effects | Osteoporosis - chemically induced | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Prostatic Neoplasms - surgery | Antibodies, Monoclonal - pharmacology | Spinal Fractures - epidemiology | Bone Density Conservation Agents - therapeutic use | Lumbar Vertebrae - drug effects | Denosumab | Bone Density Conservation Agents - pharmacology | Orchiectomy | Bone Density - drug effects | Androgen Antagonists - therapeutic use | Aged | Androgen Antagonists - adverse effects | Fractures, Bone - prevention & control | Osteoporosis | Bone density | Prostate cancer | Older people | Men | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2008, Issue 4, p. CD005088
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 18, pp. 1714 - 1723
Journal Article
Injury, ISSN 0020-1383, 2007, Volume 39, Issue 2, pp. 224 - 231
Journal Article
Journal Article
Journal Article